[1] Mathurin P, Lucey MR. Management of alcoholic hepatitis.J Hepatol, 2012,56:S39-45. [2] 朱冰,刘鸿凌,刘利敏,等.4132例酒精性肝病临床特征分析.中华肝脏病杂志,2015,23: 680-683. [3] 张野,聂青和. 1892例肝衰竭患者并发症及死亡原因分析. 实用肝脏病杂志,2014,17: 129-132. [4] 刘晓燕,陈婧,王晓霞,等. 3233例急性、亚急性、慢加急肝衰竭病因特点分析. 临床医学工程, 2012,05: 823-825. [5] 中华医学会肝病学分会脂肪肝和酒精性肝病学组. 酒精性肝病诊疗指南. 临床肝胆病杂志,2010,26: 3229-232. [6] 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2012年版). 中华肝脏病杂志, 2013, 21: 177-183. [7] Rocco A, Compare D, Angrisani D, et al. Alcoholic disease: Liver and beyond. World J Gastroenterol, 2014, 20: 14652-14659. [8] Shen Z, Li YM, Yu CH, et al. Risk factors for alcohol-related liver injury in the island population of China: A population-based case-control study. World J Gastroenterol, 2008, 14:2255-2261. [9] Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med, 2009, 360:2758-2769. [10] 单晓辉,郝书理,孙颖,等. 酒精性肝硬化与乙型肝炎肝硬化、丙型肝炎肝硬化及自身免疫性肝硬化临床特点对比分析. 传染病信息,2013,26: 279-283. [11] 王菲,郑娉娉,王炳元,等. 酒精性肝硬化患者的临床特征. 传染病信息,2011, 24: 271-274. [12] Voican CS, Perlemuter G, Naveau S. Mechanisms of the inflammatory reaction implicated in alcoholic hepatitis: 2011 update. Clin Res Hepatol Gastroenterol, 2011, 35:465-474. [13] 汪正辉, 王泰龄. 酒精性肝病. 北京: 中国医药科技出版社,2001: 128-135. [14] 王乐,陈姗姗. 甲胎蛋白和胆碱脂酶水平对重型肝炎患者预后的判断价值分析. 中国卫生标准管理,2016,08:150-151. [15] Yeluru A, Cuthbert JA, Casey L, et al. Alcoholic Hepatitis: risk factors, pathogenesis, and approach to treatment. Alcohol Clini Exp Res, 2016, 40: 246-255. [16] Ofliver EAF. EASL Clinical Practical Guidelines: Management of Alcoholic Liver Disease. J Hepatol, 2012, 57: 399-420. [17] Toshikuni N, Izumi A, Nishino K, et al. Comparison of outcomes between patients with alcoholic cirrhosis and those with hepatitis C virus-related cirrhosis. J Gastroenterol Hepatol, 2009, 24:1276-1283. [18] 朱冰,刘利敏,刘鸿凌. 重症酒精性肝炎治疗进展. 实用肝脏病杂志,2016, 29: 117-120. [19] Shasthry SM, Sarin SK. New treatment options for alcoholic hepatitis. World J Gastroenterol, 2016: 3892-3906. |